Surgery Partners Inc [SGRY] stock prices are down -1.36% to $19.61 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SGRY shares have lost -3.16% over the last week, with a monthly amount drifted -13.80%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Surgery Partners Inc [NASDAQ: SGRY] stock has seen the most recent analyst activity on December 16, 2024, when BofA Securities initiated its Buy rating and assigned the stock a price target of $30. Previously, UBS started tracking the stock with Buy rating on October 14, 2024, and set its price target to $38. On October 11, 2024, KeyBanc Capital Markets initiated with a Sector Weight rating. Macquarie started tracking the stock assigning a Outperform rating and suggested a price target of $31 on June 28, 2024. Barclays initiated its recommendation with a Equal Weight and recommended $35 as its price target on March 06, 2024. TD Cowen upgraded its rating to Outperform for this stock on November 14, 2023, and downed its price target to $35. In a note dated June 02, 2023, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $42 to $45.
The stock price of Surgery Partners Inc [SGRY] has been fluctuating between $19.83 and $35.29 over the past year. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $19.61 at the most recent close of the market. An investor can expect a potential return of 78.48% based on the average SGRY price forecast.
Analyzing the SGRY fundamentals
The Surgery Partners Inc [NASDAQ:SGRY] reported sales of 2.99B for trailing twelve months, representing a surge of 14.29%. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.03 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.34 points at the first support level, and at 19.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.08, and for the 2nd resistance point, it is at 20.55.
Ratios To Look Out For
It’s worth pointing out that Surgery Partners Inc [NASDAQ:SGRY]’s Current Ratio is 1.80. In addition, the Quick Ratio stands at 1.66 and the Cash Ratio stands at 0.39. Considering the valuation of this stock, the price to sales ratio is 0.83, the price to book ratio is 1.31.
Transactions by insiders
Recent insider trading involved Bradley Owens, Officer, that happened on Sep 05 ’24 when 9241.0 shares were purchased. National Group President, Bane Harrison R. completed a deal on Sep 04 ’24 to sell 6325.0 shares. Meanwhile, Officer Harrison Bane bought 6325.0 shares on Sep 04 ’24.
